Study on Detection and Clinical Significance of t-PA,PAI-1 in Acute Cerebrovascular Disease
Chinese Journal of Stroke(2012)
摘要
Objective To explore the change of some factors tissue-type plasminogen activator(t-PA) and plasminogen activator inhibitor-1(PAI-1) in the patients with acute cerebrovascular disease and to provide some theorical evidences for the clinical treatment. Methods The level of t-PA,PAI-1 antigen in the 78 patients with acute cerebral hemorrhage, cerebral infarction and transient ischemic attack(TlA) was determined by enzyme-linked immunosorbnent assay(ELlSA) from October 2007 to September 2008.These data were compared with control group,which contains 22 patients. Results To the cerebral hemorrhage,the level of t-PA of experimental group was higher than those of the control group(P0.001).The level of PAI-I antigen was lower than those of the control group(P0.001).The differences between the experimental group and the control group were significant.To the cerebral infarction,the level of t-PA and PAI-1 antigen of experimental group was higher than those of the control group(P0.001).In TIA,the level of PAI-1 antigen in experimental group was higher than those in control group(P0.001).The level of t-PA was lower(P=0.006).The differences between the experimental group and the control group were significant(P0.001). Conclusion To the patients with acute cerebrovascular diseases,there is disturbance of blood coagulation,anticoagulation and fibrolysis.
更多查看译文
关键词
clinical significance
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要